Peltzer, N;
Walczak, H;
(2019)
Endothelial Cell Killing by TAK1 Inhibition: A Novel Anti-angiogenic Strategy in Cancer Therapy.
Developmental Cell
, 48
(2)
pp. 127-128.
10.1016/j.devcel.2019.01.011.
Preview |
Text
181228_Naito Preview.pdf - Accepted Version Download (160kB) | Preview |
Abstract
TAK1 is a key mediator of proinflammatory signals. In this issue of Developmental Cell, Naito et al. (2019) report that TAK1 loss from endothelial cells in adult mice results in intestinal and hepatic vascular destruction due to TNF-induced death of endothelial cells. Additionally, endothelial TAK1 deletion reduces tumor burden.
Archive Staff Only
View Item |